Enhanced Recovery With Liposomal Bupivacaine in Orthognathic Surgery
Status:
Unknown status
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
The proposed study design is a prospective, clinical trial comparing control group patients
(CG; ncg = 30) that will undergo conventional perioperative management without an ERAS
protocol and standard bupivacaine intraoperative nerve block to randomized treatment group
patients that will receive an intraoperative V2 trigeminal nerve block using LB (TG; ntg =
30).